Metastatic Thyroid Gland Carcinoma

8 clinical trials · Condition

Record	Firm	Date
Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer (NCT04171622)	M.D. Anderson Cancer Center	2021-11-04
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial (NCT04693377)	M.D. Anderson Cancer Center	2021-03-16
Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer (NCT04731740)	Saint Petersburg State University, Russia	2020-12-28
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer (NCT04061980)	Providence Health & Services	2020-10-30
Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer (NCT03181100)	M.D. Anderson Cancer Center	2017-07-27
Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer (NCT02393690)	Academic and Community Cancer Research United	2015-05-04
Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer (NCT02152995)	National Cancer Institute (NCI)	2014-08-14
Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery (NCT01947023)	National Cancer Institute (NCI)	2013-09-27

Every clearance here is in the API, with alerts when new ones post.